Wall Street Recommendations for GlaxoSmithKline after 1Q18
GlaxoSmithKline beat Wall Street Analysts’ estimates for earnings per share (or EPS) and revenues for 1Q18. It reported EPS of 24.60 pence on revenues of 7.22 billion pounds, compared to analysts’ estimated EPS of 24.21 pence at revenues of 7.20 billion pounds.